CMB 0.00% 40.0¢ cambium bio limited

Ann: Regeneus to be granted new key Progenza patent in U.S., page-3

  1. 196 Posts.
    lightbulb Created with Sketch. 29
    Interesting how they managed to mention Corona in there.

    The patent to be granted for Progenza also covers Acute Respiratory Distress Syndrome
    (ARDS), an inflammatory lung condition identified as a cause of death among patients
    diagnosed with COVID-191

 
watchlist Created with Sketch. Add CMB (ASX) to my watchlist
(20min delay)
Last
40.0¢
Change
0.000(0.00%)
Mkt cap ! $4.772M
Open High Low Value Volume
41.0¢ 41.0¢ 40.0¢ $819 2K

Buyers (Bids)

No. Vol. Price($)
1 923 40.5¢
 

Sellers (Offers)

Price($) Vol. No.
50.0¢ 14500 1
View Market Depth
Last trade - 15.14pm 17/07/2024 (20 minute delay) ?
CMB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.